Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: Experience of the non-Hodgkin's lymphoma pathologic classification project

1990 ◽  
Vol 18 (2) ◽  
pp. 89-96 ◽  
Author(s):  
Richard Simon ◽  
Sylvain Durrleman ◽  
Richard T. Hoppe ◽  
Gianni Bonadonna ◽  
Clara D. Bloomfield ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Hodgkin’S Lymphoma ◽  
Large Cell ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Pathologic Classification ◽  
Classification Project ◽  
Hodgkin's Lymphomas

Primary Large-Cell Non-Hodgkin's Lymphoma of the Testis: A Retrospective Analysis of Patterns of Failure and Prognostic Factors

2001 ◽  
Vol 2 (2) ◽  
pp. 109-115 ◽  
Author(s):  
John F. Seymour ◽  
Benjamin Solomon ◽  
Max M. Wolf ◽  
E. Henry Janusczewicz ◽  
Andrew Wirth ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Retrospective Analysis ◽  
Hodgkin’S Lymphoma ◽  
Large Cell ◽  
Hodgkin's Lymphoma ◽  
Patterns Of Failure ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma

scholarly journals Systemic anaplastic large-cell lymphoma: Results from the non-Hodgkin's lymphoma classification project

2001 ◽  
Vol 67 (3) ◽  
pp. 172-178 ◽  
Author(s):  
Dennis D. Weisenburger ◽  
James R. Anderson ◽  
Jacques Diebold ◽  
Randy D. Gascoyne ◽  
Kenneth A. MacLennan ◽  
...  
Keyword(s):  
Anaplastic Large Cell Lymphoma ◽  
Hodgkin’S Lymphoma ◽  
Cell Lymphoma ◽  
Large Cell ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Large Cell Lymphoma ◽  
Classification Project ◽  
Lymphoma Classification

Intestinal Non-Hodgkin’s Lymphoma: A Multicenter Prospective Clinical Study From the German Study Group on Intestinal Non-Hodgkin’s Lymphoma

2003 ◽  
Vol 21 (14) ◽  
pp. 2740-2746 ◽  
Author(s):  
Severin Daum ◽  
Reiner Ullrich ◽  
Walter Heise ◽  
Bettina Dederke ◽  
Hans-Dieter Foss ◽  
...  
Keyword(s):  
Hodgkin’S Lymphoma ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Emergency Operation ◽  
Large Cell ◽  
Hodgkin's Lymphoma ◽  
Prospective Clinical Study ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Hodgkin's Lymphomas

Purpose: Intestinal non-Hodgkin’s lymphomas are not well characterized. We therefore studied prospectively their clinical features and response to standardized therapy. Patients and Methods: Fifty-six patients with primary intestinal lymphoma were included in a prospective, nonrandomized multicenter study. Lymphoma resection was recommended and staging was performed according to the Ann Arbor classification. Patients were scheduled to receive six cycles of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) chemotherapy, and at stages EIII to EIV, they received additional involved-field radiotherapy. Corticosteroids were used in patients who could not receive chemotherapy. Results: Thirty-five patients had intestinal T-cell lymphoma (ITCL), 21 patients had intestinal B-cell lymphoma (IBCL; 18 diffuse large-cell lymphomas, two marginal-cell lymphomas, and one follicle-center lymphoma). Thirty-four patients at stages EI to EII (14 ITCL and 20 IBCL) and nine patients at stages EIII to EIV (all ITCL) received chemotherapy. No patient in stages EIII to EIV received radiotherapy, because death occurred in 12 of 14 patients. Two-year cumulative survival in patients with IBCL was 94% (95% CI, 82% to 100%) and higher than in patients with ITCL (28% [95% CI, 13% to 43%]; P < .0001), even when only stages EI to EII were considered (ITCL, 37.5% [95% CI, 16.5% to 58.5%]; P < .0001). IBCL patients compared with ITCL patients were at lower lymphoma stages (P < .01), had higher Karnofsky status (P < .005), had intestinal perforation less often (P < .05), required emergency operation less often (P < .05), received CHOP (P < .05) more often, and reached complete remission (P < .0005) more frequently. Conclusion: IBCL patients at stages EI and EII respond well to chemotherapy, but the prognosis and treatment of ITCL patients is unsatisfactory.

scholarly journals Primary Non-Hodgkin's Lymphoma involving Parotid Gland: A Rare Entity

2017 ◽  
Vol 7 (1) ◽  
pp. 71-75
Author(s):  
Sushrut Vaidya ◽  
Srivalli Natrajan ◽  
Sneha Kadam
Keyword(s):  
Parotid Gland ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Resected Specimen ◽  
Rare Entity ◽  
Primary Tumors ◽  
Nerve Preservation ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Hodgkin's Lymphomas

ABSTRACT Non-Hodgkin's lymphomas constitute 25 to 40% of all lymphomas. The gastrointestinal tract is the most common site followed by the head and neck area. Salivary gland involvement is a very rare entity and is involved in 0.5 to 5% of all cases. Among all the major salivary glands, the parotid gland is commonly involved followed by the submandibular glands. Misdiagnosis often leads to unnecessary diagnostic procedures, which leads to delay in initiation of appropriate treatment. It is often difficult to diagnose the distinction between lymphoma developing primarily in the parotid gland tissue and in the intraparotid lymph nodes. As per the reports, primary tumors of the parotid gland show no characteristic features on diagnostic imaging, reflecting none of their histological findings. We represent a case of a 61-year-old female who presented with painless, gradually increasing mass in the right parotid region. Imaging studies were suggestive of an infiltrative mass lesion involving right the parotid gland. The patient underwent superficial parotidectomy along with the excision of the part of the deep lobe posterior to submandibular gland with facial nerve preservation. Histopathology of the resected specimen shows infiltrates of lymphocytes into the glandular parenchyma destroying its normal lobular organization and disrupting the normal glandular architecture. How to cite this article Vaidya S, Natrajan S, Kadam S. Primary Non-Hodgkin's Lymphoma involving Parotid Gland: A Rare Entity. J Contemp Dent 2017;7(1):71-75.

Sign in / Sign up

Export Citation Format

Share Document